Mortality in Iranian Patients with Parkinson’s Disease: Cumulative Impact of Cardiovascular Comorbidities as One Major Risk Factor
Mortality rate, life expectancy, survival, and the impact of comorbidities on them in people with Parkinson’s disease (PD) need to be assessed in settings with different sociodemographic backgrounds. We investigated mortality features in Iranian PD patients focusing on the role of cardiovascular mul...
Saved in:
| Main Authors: | Seyed-Mohammad Fereshtehnejad, Azadeh Shafieesabet, Mahdiyeh Shafieesabet, Gholam Ali Shahidi, Ahmad Delbari, Johan Lökk |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Parkinson's Disease |
| Online Access: | http://dx.doi.org/10.1155/2015/834796 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mediating Effect of Mutuality on Health-Related Quality of Life in Patients with Parkinson’s Disease
by: Michaela Karlstedt, et al.
Published: (2018-01-01) -
A report of the Iranian Parkinson’s disease registry
by: Mehri Salari, et al.
Published: (2025-08-01) -
Prevalence of Comorbidities and Their Impact on One-year Outcomes in Iranian Patients Hospitalized with ST-segment Elevation Myocardial Infarction
by: Mohammad Rozbahani, et al.
Published: (2024-09-01) -
Development of Iranian clinical practice guidelines: An experience in cardiovascular diseases-A policy brief
by: Nizal Sarrafzadegan, et al.
Published: (2025-03-01) -
COVID-19 and cardiovascular comorbidity: novel approaches to reduce mortality
by: S. S. Bunova, et al.
Published: (2021-07-01)